 | • レポートコード：QFJ1-5857 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、転移性悪性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、標的療法、その他）、用途別市場規模（病院、医療研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・転移性悪性黒色腫治療の市場動向 ・企業の競争状況、市場シェア ・転移性悪性黒色腫治療の種類別市場規模と予測2016-2027（免疫療法、標的療法、その他） ・転移性悪性黒色腫治療の用途別市場規模と予測2016-2027（病院、医療研究機関、その他） ・転移性悪性黒色腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・転移性悪性黒色腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・転移性悪性黒色腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・転移性悪性黒色腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・転移性悪性黒色腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Pfizer、Janssen Biotech、Roche、Navidea、Novartis、Bristol-Myers Squibb、Enzon Pharmaceuticals、Exelixis、GlaxoSmithKline、Ono Pharmaceutical、Amgen） ・結論 |
Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, in order to reduce the cardiopulmonary compression.Chemotherapy and immunotherapy can be used in patients with better systemic status, but malignant melanoma is not sensitive to the former, while the latter has a certain effect on enhancing the patient’s immunity.Radiotherapy can be used as an experimental therapy and can also confirm the presence or absence of cardiac metastasis.Arrhythmias are sometimes controlled by digitalis therapy.
Market Analysis and Insights: Global Metastatic Malignant Melanoma Therapy Market
The global Metastatic Malignant Melanoma Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Malignant Melanoma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Malignant Melanoma Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Malignant Melanoma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Malignant Melanoma Therapy market.
Global Metastatic Malignant Melanoma Therapy Scope and Market Size
Metastatic Malignant Melanoma Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Malignant Melanoma Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Immunotherapy
Targeted Therapy
Other
Segment by Application
Hospital
Medical Research Organization
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Pfizer
Janssen Biotech
Roche
Navidea
Novartis
Bristol-Myers Squibb
Enzon Pharmaceuticals
Exelixis
GlaxoSmithKline
Ono Pharmaceutical
Amgen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunotherapy
1.2.3 Targeted Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Research Organization
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Malignant Melanoma Therapy Market Perspective (2016-2027)
2.2 Metastatic Malignant Melanoma Therapy Growth Trends by Regions
2.2.1 Metastatic Malignant Melanoma Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Malignant Melanoma Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Malignant Melanoma Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Malignant Melanoma Therapy Industry Dynamic
2.3.1 Metastatic Malignant Melanoma Therapy Market Trends
2.3.2 Metastatic Malignant Melanoma Therapy Market Drivers
2.3.3 Metastatic Malignant Melanoma Therapy Market Challenges
2.3.4 Metastatic Malignant Melanoma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Malignant Melanoma Therapy Players by Revenue
3.1.1 Global Top Metastatic Malignant Melanoma Therapy Players by Revenue (2016-2021)
3.1.2 Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Malignant Melanoma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Malignant Melanoma Therapy Revenue
3.4 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio
3.4.1 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Malignant Melanoma Therapy Revenue in 2020
3.5 Metastatic Malignant Melanoma Therapy Key Players Head office and Area Served
3.6 Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service
3.7 Date of Enter into Metastatic Malignant Melanoma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Malignant Melanoma Therapy Breakdown Data by Type
4.1 Global Metastatic Malignant Melanoma Therapy Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Type (2022-2027)
5 Metastatic Malignant Melanoma Therapy Breakdown Data by Application
5.1 Global Metastatic Malignant Melanoma Therapy Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Metastatic Malignant Melanoma Therapy Market Size (2016-2027)
6.2 North America Metastatic Malignant Melanoma Therapy Market Size by Type
6.2.1 North America Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021)
6.2.2 North America Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027)
6.2.3 North America Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2027)
6.3 North America Metastatic Malignant Melanoma Therapy Market Size by Application
6.3.1 North America Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021)
6.3.2 North America Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027)
6.3.3 North America Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2027)
6.4 North America Metastatic Malignant Melanoma Therapy Market Size by Country
6.4.1 North America Metastatic Malignant Melanoma Therapy Market Size by Country (2016-2021)
6.4.2 North America Metastatic Malignant Melanoma Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metastatic Malignant Melanoma Therapy Market Size (2016-2027)
7.2 Europe Metastatic Malignant Melanoma Therapy Market Size by Type
7.2.1 Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2027)
7.3 Europe Metastatic Malignant Melanoma Therapy Market Size by Application
7.3.1 Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2027)
7.4 Europe Metastatic Malignant Melanoma Therapy Market Size by Country
7.4.1 Europe Metastatic Malignant Melanoma Therapy Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Malignant Melanoma Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type
8.2.1 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application
8.3.1 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Region
8.4.1 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastatic Malignant Melanoma Therapy Market Size (2016-2027)
9.2 Latin America Metastatic Malignant Melanoma Therapy Market Size by Type
9.2.1 Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2027)
9.3 Latin America Metastatic Malignant Melanoma Therapy Market Size by Application
9.3.1 Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2027)
9.4 Latin America Metastatic Malignant Melanoma Therapy Market Size by Country
9.4.1 Latin America Metastatic Malignant Melanoma Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Malignant Melanoma Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type
10.2.1 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application
10.3.1 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Country
10.4.1 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Metastatic Malignant Melanoma Therapy Introduction
11.1.4 Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Metastatic Malignant Melanoma Therapy Introduction
11.2.4 Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Janssen Biotech
11.3.1 Janssen Biotech Company Details
11.3.2 Janssen Biotech Business Overview
11.3.3 Janssen Biotech Metastatic Malignant Melanoma Therapy Introduction
11.3.4 Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.3.5 Janssen Biotech Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Metastatic Malignant Melanoma Therapy Introduction
11.4.4 Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Navidea
11.5.1 Navidea Company Details
11.5.2 Navidea Business Overview
11.5.3 Navidea Metastatic Malignant Melanoma Therapy Introduction
11.5.4 Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.5.5 Navidea Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Metastatic Malignant Melanoma Therapy Introduction
11.6.4 Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Introduction
11.7.4 Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Enzon Pharmaceuticals
11.8.1 Enzon Pharmaceuticals Company Details
11.8.2 Enzon Pharmaceuticals Business Overview
11.8.3 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Introduction
11.8.4 Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.8.5 Enzon Pharmaceuticals Recent Development
11.9 Exelixis
11.9.1 Exelixis Company Details
11.9.2 Exelixis Business Overview
11.9.3 Exelixis Metastatic Malignant Melanoma Therapy Introduction
11.9.4 Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.9.5 Exelixis Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Introduction
11.10.4 GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
11.11 Ono Pharmaceutical
11.11.1 Ono Pharmaceutical Company Details
11.11.2 Ono Pharmaceutical Business Overview
11.11.3 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Introduction
11.11.4 Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.11.5 Ono Pharmaceutical Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Metastatic Malignant Melanoma Therapy Introduction
11.12.4 Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021)
11.12.5 Amgen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Other
Table 5. Global Metastatic Malignant Melanoma Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metastatic Malignant Melanoma Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metastatic Malignant Melanoma Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2016-2021)
Table 9. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2022-2027)
Table 11. Metastatic Malignant Melanoma Therapy Market Trends
Table 12. Metastatic Malignant Melanoma Therapy Market Drivers
Table 13. Metastatic Malignant Melanoma Therapy Market Challenges
Table 14. Metastatic Malignant Melanoma Therapy Market Restraints
Table 15. Global Metastatic Malignant Melanoma Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Metastatic Malignant Melanoma Therapy Market Share by Players (2016-2021)
Table 17. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2020)
Table 18. Ranking of Global Top Metastatic Malignant Melanoma Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Metastatic Malignant Melanoma Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service
Table 22. Date of Enter into Metastatic Malignant Melanoma Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Metastatic Malignant Melanoma Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Metastatic Malignant Melanoma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Metastatic Malignant Melanoma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Metastatic Malignant Melanoma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Metastatic Malignant Melanoma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Metastatic Malignant Melanoma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Metastatic Malignant Melanoma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Metastatic Malignant Melanoma Therapy Product
Table 65. Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Metastatic Malignant Melanoma Therapy Product
Table 70. Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Janssen Biotech Company Details
Table 73. Janssen Biotech Business Overview
Table 74. Janssen Biotech Metastatic Malignant Melanoma Therapy Product
Table 75. Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 76. Janssen Biotech Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Metastatic Malignant Melanoma Therapy Product
Table 80. Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Navidea Company Details
Table 83. Navidea Business Overview
Table 84. Navidea Metastatic Malignant Melanoma Therapy Product
Table 85. Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 86. Navidea Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Metastatic Malignant Melanoma Therapy Product
Table 90. Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Product
Table 95. Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Enzon Pharmaceuticals Company Details
Table 98. Enzon Pharmaceuticals Business Overview
Table 99. Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 100. Enzon Pharmaceuticals Recent Development
Table 101. Exelixis Company Details
Table 102. Exelixis Business Overview
Table 103. Exelixis Metastatic Malignant Melanoma Therapy Product
Table 104. Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 105. Exelixis Recent Development
Table 106. GlaxoSmithKline Company Details
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Metastatic Malignant Melanoma Therapy Product
Table 109. GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 110. GlaxoSmithKline Recent Development
Table 111. Ono Pharmaceutical Company Details
Table 112. Ono Pharmaceutical Business Overview
Table 113. Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Product
Table 114. Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 115. Ono Pharmaceutical Recent Development
Table 116. Amgen Company Details
Table 117. Amgen Business Overview
Table 118. Amgen Metastatic Malignant Melanoma Therapy Product
Table 119. Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2016-2021) & (US$ Million)
Table 120. Amgen Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Malignant Melanoma Therapy Market Share by Type: 2020 VS 2027
Figure 2. Immunotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Other Features
Figure 5. Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Medical Research Organization Case Studies
Figure 8. Other Case Studies
Figure 9. Metastatic Malignant Melanoma Therapy Report Years Considered
Figure 10. Global Metastatic Malignant Melanoma Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Metastatic Malignant Melanoma Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Metastatic Malignant Melanoma Therapy Market Share by Regions: 2020 VS 2027
Figure 13. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2022-2027)
Figure 14. Global Metastatic Malignant Melanoma Therapy Market Share by Players in 2020
Figure 15. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Metastatic Malignant Melanoma Therapy Revenue in 2020
Figure 17. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2016-2021)
Figure 18. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2022-2027)
Figure 19. North America Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Metastatic Malignant Melanoma Therapy Market Share by Type (2016-2027)
Figure 21. North America Metastatic Malignant Melanoma Therapy Market Share by Application (2016-2027)
Figure 22. North America Metastatic Malignant Melanoma Therapy Market Share by Country (2016-2027)
Figure 23. United States Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Metastatic Malignant Melanoma Therapy Market Share by Type (2016-2027)
Figure 27. Europe Metastatic Malignant Melanoma Therapy Market Share by Application (2016-2027)
Figure 28. Europe Metastatic Malignant Melanoma Therapy Market Share by Country (2016-2027)
Figure 29. Germany Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Share by Region (2016-2027)
Figure 39. China Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Metastatic Malignant Melanoma Therapy Market Share by Type (2016-2027)
Figure 47. Latin America Metastatic Malignant Melanoma Therapy Market Share by Application (2016-2027)
Figure 48. Latin America Metastatic Malignant Melanoma Therapy Market Share by Country (2016-2027)
Figure 49. Mexico Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Share by Country (2016-2027)
Figure 55. Turkey Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Merck Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 60. Janssen Biotech Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 62. Navidea Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 65. Enzon Pharmaceuticals Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 66. Exelixis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 68. Ono Pharmaceutical Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 世界の転移性黒色腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metastatic Melanoma Treatment Market The global Metastatic Melanoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- 世界の転移性ブドウ膜メラノーマ治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metastatic Uveal Melanoma Thereapeutics Market The global Metastatic Uveal Melanoma Thereapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis…